A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven phase III study to investigate the safety and efficacy of finerenone in addition to standard of care Read more about A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven phase III study to investigate the safety and efficacy of finerenone in addition to standard of care
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Event Driven Phase III Study to Investigate the Safety & Efficacy of Finerenone Read more about A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Event Driven Phase III Study to Investigate the Safety & Efficacy of Finerenone
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Event Driven Phase III Study to Investigate the Safety & Efficacy of Finerenone Read more about A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Event Driven Phase III Study to Investigate the Safety & Efficacy of Finerenone
Diabetes Incidence Prevalence and Medications Use Read more about Diabetes Incidence Prevalence and Medications Use
Epstein-Barr Virus Antisense Transcription - Progress Report Read more about Epstein-Barr Virus Antisense Transcription - Progress Report
P01: Noncoding RNAs in Herpersvinus Biology & AIDS Malignancies/TU's Project 2: "Epstein-Barr virus LMP2 IncRNAs" + Core B: "Virus RNA-seq & Bioinformatics Core" - SUB with UF Read more about P01: Noncoding RNAs in Herpersvinus Biology & AIDS Malignancies/TU's Project 2: "Epstein-Barr virus LMP2 IncRNAs" + Core B: "Virus RNA-seq & Bioinformatics Core" - SUB with UF
Center for Translational Viral Oncology (CTVO) Read more about Center for Translational Viral Oncology (CTVO)
Center for Translational Viral Oncology (CTVO) Read more about Center for Translational Viral Oncology (CTVO)
